Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Amgen

Status: Completed

Conditions: Rheumatoid Arthritis

Treatments: Drug: DMARD

Study type: Observational

Funder types: Industry

Identifiers

NCT00116714

016.0034

20021634

Details and patient eligibility

About

The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.

Enrollment: 4,968 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Fulfillment of the 1987 American Rheumatism Association criteria for RA
• Currently requiring a new DMARD (change or addition)

Exclusion criteria

• Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol
• Nursing or pregnant women
• Patients with active infection

Trial design

4,968 participants in 1 patient group

Observation

Treatment:

Drug: DMARD